|Publication status||Published - 15-Apr-2013|
|Event||104th Annual Meeting of the American-Association-for-Cancer-Research (AACR) - Washington, Washington, United States|
Duration: 6-Apr-2013 → 10-Apr-2013
Pre-treatment EGFR mutation analysis predicts clinical outcome in a retrospective analysis of 24 non-squamous non-small-cell lung cancer (NSCLC) patients treated with second line afatinib.
Research output: Contribution to journal › Meeting Abstract › Academic